News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Bioniche Pharma Ltd. Adds On, Aquires Drugs from Xanodyne Pharmaceuticals, Inc.



11/16/2009 7:59:45 AM

Pehub.com -- Bioniche Pharma, an injectable drugmaker owned by Roundtable Healthcare Partners, has acquired Duraclon (clonidine hydrochloride injection) and Methadone Hydrochloride Injection USP from Xanodyne Pharmaceuticals Inc. No financial terms were disclosed. Xanodyne has raised over $230 million in VC funding, from firms like AIG Investments, Aisling Capital, Blue Chip Venture Co., Essex Woodlands Health Ventures, HealthCare Ventures, MPM Capital and Union Springs.



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES